Deutsche Bank’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-94,911
| Closed | -$122K | – | 4405 |
|
|
2022
Q1 | $122K | Sell |
94,911
-12,949
| -12% | -$11.9K | ﹤0.01% | 3504 |
|
|
2021
Q4 | $137K | Sell |
107,860
-10,280
| -9% | -$18.4K | ﹤0.01% | 3562 |
|
|
2021
Q3 | $257K | Buy |
118,140
+2,067
| +2% | +$5.65K | ﹤0.01% | 3436 |
|
|
2021
Q2 | $434K | Buy |
116,073
+7,618
| +7% | +$26.5K | ﹤0.01% | 3310 |
|
|
2021
Q1 | $353K | Sell |
108,455
-5,327
| -5% | -$19.1K | ﹤0.01% | 3318 |
|
|
2020
Q4 | $388K | Buy |
113,782
+7,026
| +7% | +$28.9K | ﹤0.01% | 3076 |
|
|
2020
Q3 | $436K | Sell |
106,756
-387,275
| -78% | -$1.47M | ﹤0.01% | 2736 |
|
|
2020
Q2 | $1.67M | Buy |
494,031
+22,702
| +5% | +$66.1K | ﹤0.01% | 1903 |
|
|
2020
Q1 | $1.1M | Buy |
471,329
+307,325
| +187% | +$841K | ﹤0.01% | 2041 |
|
|
2019
Q4 | $595K | Sell |
164,004
-68,940
| -30% | -$557K | ﹤0.01% | 2640 |
|
|
2019
Q3 | $1.93M | Sell |
232,944
-585,586
| -72% | -$4.74M | ﹤0.01% | 1938 |
|
|
2019
Q2 | $7.05M | Buy |
818,530
+387,336
| +90% | +$3.46M | ﹤0.01% | 1596 |
|
|
2019
Q1 | $4.61M | Buy |
431,194
+22,761
| +6% | +$244K | ﹤0.01% | 1922 |
|
|
2018
Q4 | $3.57M | Sell |
408,433
-307,514
| -43% | -$3.92M | ﹤0.01% | 2018 |
|
|
2018
Q3 | $12M | Buy |
715,947
+198,361
| +38% | +$4.29M | 0.01% | 1503 |
|
|
2018
Q2 | $10.8M | Sell |
517,586
-212,104
| -29% | -$3.93M | 0.01% | 1669 |
|
|
2018
Q1 | $11.7M | Buy |
729,690
+311,925
| +75% | +$6.18M | 0.01% | 1482 |
|
|
2017
Q4 | $7.92M | Sell |
417,765
-492,604
| -54% | -$8.92M | 0.01% | 1667 |
|
|
2017
Q3 | $12.8M | Buy |
910,369
+154,646
| +20% | +$1.4M | 0.01% | 1288 |
|
|
2017
Q2 | $5.63M | Buy |
755,723
+211,897
| +39% | +$1.38M | ﹤0.01% | 1841 |
|
|
2017
Q1 | $3.53M | Sell |
543,826
-686,843
| -56% | -$3.84M | ﹤0.01% | 1889 |
|
|
2016
Q4 | $5.45M | Sell |
1,230,669
-441,433
| -26% | -$1.85M | ﹤0.01% | 1621 |
|
|
2016
Q3 | $7.81M | Sell |
1,672,102
-51,869
| -3% | -$307K | 0.01% | 1469 |
|
|
2016
Q2 | $11.3M | Buy |
1,723,971
+358,304
| +26% | +$2.53M | 0.01% | 1224 |
|
|
2016
Q1 | $8.68M | Buy |
1,365,667
+33,623
| +3% | +$173K | 0.01% | 1357 |
|
|
2015
Q4 | $8.03M | Buy |
1,332,044
+336,154
| +34% | +$1.92M | 0.01% | 1467 |
|
|
2015
Q3 | $5.95M | Buy |
995,890
+388,959
| +64% | +$2.7M | ﹤0.01% | 1677 |
|
|
2015
Q2 | $4.15M | Buy |
606,931
+105,133
| +21% | +$668K | ﹤0.01% | 1924 |
|
|
2015
Q1 | $3.04M | Buy |
501,798
+220,317
| +78% | +$1.47M | ﹤0.01% | 2145 |
|
|
2014
Q4 | $1.95M | Buy |
281,481
+17,083
| +6% | +$126K | ﹤0.01% | 2692 |
|
|
2014
Q3 | $2.15M | Sell |
264,398
-99,060
| -27% | -$775K | ﹤0.01% | 2474 |
|
|
2014
Q2 | $2.95M | Buy |
363,458
+80,731
| +29% | +$613K | ﹤0.01% | 2188 |
|
|
2014
Q1 | $2.22M | Buy |
282,727
+36,888
| +15% | +$312K | ﹤0.01% | 2343 |
|
|
2013
Q4 | $2.17M | Buy |
245,839
+108,411
| +79% | +$968K | ﹤0.01% | 2243 |
|
|
2013
Q3 | $1.15M | Sell |
137,428
-21,629
| -14% | -$175K | ﹤0.01% | 2873 |
|
|
2013
Q2 | $1.18M | Buy |
+159,057
| New | +$1.22M | ﹤0.01% | 2578 |
|
Other funds holding SPPI
ACM
E
Deutsche Bank's SPPI Position: Q2 2022 in Review
Deutsche Bank sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 94,911 shares — an estimated $122K sold.
Deutsche Bank first reported a position in SPPI in Q2 2013 and held it in 36 quarters. The position peaked at $12.8M in Q3 2017. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.
- Deutsche Bank reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
- Deutsche Bank sold 94,911 Spectrum Pharmaceuticals Inc shares in Q2 2022, an estimated $122K.
- Deutsche Bank first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 36 quarters.
- Deutsche Bank's Spectrum Pharmaceuticals Inc position peaked at $12.8M in Q3 2017.
- 86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.
Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.